This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David A. Goldstein, MD

Arch Otolaryngol Head Neck Surg. 1993;119(11):1183-1186.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE FIELD of molecular genetics presents a number of ethical questions similar to most new biomedical technologies.

About 5% of children born in the United States have genetic disorders. These abnormalities may result in a range of disabilities from mild cosmetic deformities to mental retardation to death. Molecular genetics and recombinant DNA technology may ameliorate these abnormalities, or even put an end to them. As a result, victims, the relatives of victims, and physicians have great interest in the science of genetic engineering.

Should there be limits on the information that can be investigated? What committee or confederation should be given the overall responsibility to investigate the information or to decide what information should be investigated? Once new data are generated, what portion of the information should be made available and to whom should it be made available? What are the ramifications of the newly generated data and what groups . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?